Associations of Probiotics with Vitamin D and Leptin Receptors and their Effects on Colon Cancer

  • Ranji, Peyman (Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, International Branch of Tabriz University of Medical sciences (Aras)) ;
  • Akbarzadeh, Abolfazl (Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical sciences) ;
  • Rahmati-Yamchi, Mohammad (Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical sciences)
  • Published : 2015.05.18


Colorectal cancer (CRC) is one of most common causes of cancer-related death worldwide. Recent studies have suggested that microbial and environmental factors including diet and lifestyle can impact on colon cancer development. Vitamin D deficiency and dysfunction of vitamin D receptor (VDR) also correlate with colon cancer. Moreover, leptin, a 16-kDa polypeptide, participates in the regulation of food intake and is associated with other environmental factors affecting colon cancer through the leptin receptor. Altered levels of serum leptin and patterns of expression of its receptor (LPR) may be observed in human colon tumours. Furthermore, the collected data from in vitro and in vivo studies have indicated that consuming probiotic non-pathogenic lactic acid bacteria have beneficial effects on colon cancer. Probiotics, inflammation and vitamin D/VDR have been correlated with leptin and its receptor and are also with colon cancer. Thus, in this paper, we review recent progress on the roles of probiotic, vitamin D/VDR and leptin/LPR in inflammation and colon cancer.


Colon cancer;leptin;leptin receptor;probiotic;vitamin D;vitamin D receptor


  1. Urbanska AM, Bhathena J, Martoni C, et al (2009). Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc (Min/+) mice. Dig Dis Sci, 54, 264-73.
  2. Wada K, Tanaka H, Maeda K, et al (2009). Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncology reports, 22, 1021.
  3. Weiss ST (2011). Bacterial components plus vitamin D: the ultimate solution to the asthma (autoimmune disease) epidemic? J Allergy Clin Immunol Pract, 127, 1128.
  4. Wu S, Liao AP, Xia Y, et al (2010). Vitamin D receptor negatively regulates bacterial-stimulated NF-${\kappa}B$ activity in intestine. Am J Pathol, 177, 686-97.
  5. Wu S, Sun J (2011). Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discovery Med, 11, 325.
  6. Yoon S, Wu S, Zhang Y-g, et al (2011). Probiotic regulation of vitamin D receptor in intestinal inflammation. Gastroenterology, 140, S-19.
  7. Yoon SS, Sun J (2011). Probiotics, nuclear receptor signaling, and anti-inflammatory pathways. Gastroenterology research and practice, 2011.
  8. Yu K, Yang J, Jiang Y, et al (2014). Vitamin D receptor BsmI polymorphism and colorectal cancer risk: an updated analysis. Asian Pac J Cancer Prev, 15, 4801-7.
  9. Zheng W, Wong KE, Zhang Z, et al (2012). Inactivation of the vitamin D receptor in APCmin/+ mice reveals a critical role for the vitamin D receptor in intestinal tumor growth. Int J Cancer, 130, 10-9.
  10. Zhu Y, Michelle Luo T, Jobin C, et al (2011). Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett, 309, 119-27.
  11. Zinser GM, Suckow M, Welsh J (2005). Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem Mol Biol, 97, 153-64.
  12. Ahima RS, Osei SY (2004). Leptin signaling. Physiology & Behavior, 81, 223-41.
  13. Akinci MB, Sendur M, Aksoy S, et al (2014). Serum 25-hydroxy Vitamin D status is not related to osteopenia/osteoporosis risk in colorectal cancer survivors. Asian Pac J Cancer Prev: APJCP, 15, 3377.
  14. Al-Jashamy K, Murad A, Zeehaida M, et al (2010). Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients. Asian Pac J Cancer Prev, 11, 1765-8.
  15. Aloulou N, Bastuji-Garin S, Le Gouvello S, et al (2008). Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res, 68, 9413-22.
  16. Aparicio T, Kotelevets L, Tsocas A, et al (2005). Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in ApcMin/+ mice. Gut, 54, 1136-45.
  17. Bartucci M, Svensson S, Ricci-Vitiani L, et al (2010). Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells. Endocrine-related Cancer, 17, 823-33.
  18. Basseri RJ, Basseri B, Papadakis KA (2011). Dysplasia and cancer in inflammatory bowel disease.
  19. Bolukbas FF, Kilic H, Bolukbas C, et al (2004). Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer, 4, 29.
  20. Bouillon R, Carmeliet G, Verlinden L, et al (2008). Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine Reviews, 29, 726-76.
  21. Abreu M, Kantorovich V, Vasiliauskas E, et al (2004). Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1, 25-dihydroxyvitamin D and low bone mineral density. Gut, 53, 1129-36.
  22. Abreu MT, Peek RM, Jr. (2014). Gastrointestinal malignancy and the microbiome. Gastroenterology, 146, 1534-46.
  23. Carlberg C, Dunlop TW (2006). The impact of chromatin organization of vitamin D target genes. Anticancer Research, 26, 2637-45.
  24. Collins AT, Berry PA, Hyde C, et al (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer research, 65, 10946-51.
  25. Davis CD, Milner JA (2009). Gastrointestinal microflora, food components and colon cancer prevention. J Nutritional Biochemistry, 20, 743-52.
  26. Drew JE (2012). Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin. Proceedings of the Nutrition Society, 71, 175-80.
  27. Endo H, Hosono K, Uchiyama T, et al (2011). Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut, 2010, 235754.
  28. Fearon ER (2011). Molecular genetics of colorectal cancer. Annual Review of Pathology: Mechanisms of Disease, 6, 479-507.
  29. Gianotti L, Morelli L, Galbiati F, et al (2010). A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World journal of gastroenterology: WJG, 16, 167.
  30. Guarner F, Malagelada J-R (2003). Gut flora in health and disease. The Lancet, 361, 512-9.
  31. Hardwick JC, Van Den Brink GR, Offerhaus G, et al (2001). Leptin is a growth factor for colonic epithelial cells. Gastroenterology, 121, 79-90.
  32. Hoda M, Keely S, Bertelsen L, et al (2007). Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg, 94, 346-54.
  33. Holick MF (2010). Vitamin D and health: evolution, biologic functions, and recommended dietary intakes for vitamin D. In 'Vitamin D', Eds Springer, 3-33
  34. Huang P, Chandra V, Rastinejad F (2010). Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol, 72, 247-72.
  35. Hui L, Desen W, Zhizhong P, et al (2011). Expression and biological significance of leptin, leptin receptor, VEGF, and CD34 in colorectal carcinoma. Cell Biochem Biophysics, 60, 241-4.
  36. Ishikawa H, Akedo I, Otani T, et al (2005). Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer, 116, 762-7.
  37. Ishikawa M, Kitayama J, Nagawa H (2004). Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res, 10, 4325-31.
  38. Isono M, Inoue R, Kamida T, et al (2003). Significance of leptin expression in invasive potential of pituitary adenomas. Clin Neurol Neurosurgery, 105, 111-6.
  39. Joshi RK, Lee S-A (2014). Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev, 15, 397-405.
  40. Kailasapathy K, Chin J (2000). Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunology and Cell Biology, 78, 80-8.
  41. Kaji R, Kiyoshima-Shibata J, Nagaoka M, et al (2010). Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol, 184, 3505-13.
  42. Kotnis A, Sarin R, Mulherkar R (2005). Genotype, phenotype and cancer: role of low penetrance genes and environment in tumour susceptibility. J Biosciences, 30, 93-102.
  43. Kumar M, Nagpal R, Verma V, et al (2013). Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev, 71, 23-34.
  44. Kumor A, Daniel P, Pietruczuk M, et al (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Disease, 24, 275-81.
  45. Lagishetty V, Misharin AV, Liu NQ, et al (2010). Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology, 151, 2423-32.
  46. Lee NK, Park JS, Park E, et al (2007). Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. Letters in Applied Microbiol, 44, 274-8.
  47. Leung K-C (2004). Regulation of cytokine receptor signaling by nuclear hormone receptors: a new paradigm for receptor interaction. DNA and Cell Biology, 23, 463-74.
  48. Lu R, Wu S, Xia Y, et al (2012). The vitamin D receptor, inflammatory bowel diseases, and colon cancer. Current Colorectal Cancer Reports, 8, 57-65.
  49. Matilainen JM, Rasanen A, Gynther P, et al (2010). The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1${\alpha}$, 25 (OH) 2 D 3 target genes. J Steroid Biochemistry and Molecular Biology, 121, 142-5.
  50. Matsunuma A, Horiuchi N (2007). Leptin attenuates gene expression for renal 25-hydroxyvitamin D 3-1${\alpha}$-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys, 463, 118-27.
  51. McEwan IJ 2009. Nuclear receptors: one big family, Springer.
  52. Mencarelli A, Distrutti E, Renga B, et al (2011). Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. PLoS One, 6, 22978.
  53. Menendez C, Lage M, Peino R, et al (2001). Retinoic acid and vitamin D (3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol, 170, 425-31.
  54. Mirza NN, McCloud JM, Cheetham MJ (2009). Clostridium septicum sepsis and colorectal cancer-a reminder. World J Surg Oncol, 7, 73.
  55. Mu H-J, Zou J, Xie P, et al (2014). Association of leptin receptor Lys109Arg and Gln223Arg polymorphisms with increased risk of clear cell renal cell carcinoma. Asian Pac J Cancer Prev, 15, 4211-5.
  56. O'mahony L, Feeney M, O'halloran S, et al (2001). Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Alimentary Pharmacology & Therapeutics, 15, 1219-25.
  57. Palmer HG, Gonzalez-Sancho JM, Espada J, et al (2001). Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol, 154, 369-87.
  58. Pendas-Franco N, Aguilera O, Pereira F, et al (2008). Vitamin D and Wnt/${\beta}$-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Research, 28, 2613-23.
  59. Pereira F, Larriba MJ, Munoz A (2012). Vitamin D and colon cancer. Endocrine-related cancer, 19, 51-71.
  60. Ramagopalan SV, Heger A, Berlanga AJ, et al (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Research, 20, 1352-60.
  61. Rasool S, Kadla SA, Khan T, et al (2013). Association of a VDR gene polymorphism with risk of colorectal cancer in Kashmir. Asian Pac J Cancer Prev, 14, 5833-7.
  62. Reiff C, Delday M, Rucklidge G, et al (2009). Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL# 3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases, 15, 1721-36.
  63. Reya T, Clevers H (2005). Wnt signalling in stem cells and cancer. Nature, 434, 843-50.
  64. Salageanu A (2010). Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life, 3, 416.
  65. Samuel S, Sitrin MD (2008). Vitamin D's role in cell proliferation and differentiation. Nutrition reviews, 66, 116-24.
  66. Schauber J, Dorschner RA, Coda AB, et al (2007). Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. The J Clin Invest, 117, 803-11.
  67. Sentongo TA, Semaeo EJ, Stettler N, et al (2002). Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr, 76, 1077-81.
  68. Shamsuzzaman AS, Winnicki M, Wolk R, et al (2004). Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation, 109, 2181-5.
  69. Slattery M, Ballard-Barbash R, Edwards S, et al (2003). Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control, 14, 75-84.
  70. Slattery ML, Curtin K, Sweeney C, et al (2007). Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer, 120, 656-63.
  71. Slattery ML, Wolff RK, Herrick J, et al (2008). Leptin and leptin receptor genotypes and colon cancer: Gene-gene and gene-lifestyle interactions. Int J Cancer, 122, 1611-7.
  72. Sonoda J, Pei L, Evans RM (2008). Nuclear receptors: decoding metabolic disease. FEBS letters, 582, 2-9.
  73. Stubbins RE, Hakeem A, Nunez NP (2012). Using components of the vitamin D pathway to prevent and treat colon cancer. Nutr Rev, 70, 721-9.
  74. Sun J (2010). Vitamin D and mucosal immune function. Curr Opinion Gastroenterology, 26, 591.
  75. Suzuki T, Franchi L, Toma C, et al (2007). Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS pathogens, 3, 111.
  76. Thorne J, Campbell MJ (2008). The vitamin D receptor in cancer. Proc Nutrition Society, 67, 115-27.
  77. Tutino V, Notarnicola M, Guerra V, et al (2011). Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients. Anticancer Res, 31, 3381-3.
  78. Uchiyama T, Takahashi H, Endo H, et al (2011). Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression. Int J Oncol, 39, 935.

Cited by

  1. Effects of Lactobacillus acidophilus and Bifidobacterium bifidum Probiotics on the Expression of MicroRNAs 135b, 26b, 18a and 155, and Their Involving Genes in Mice Colon Cancer pp.1867-1314, 2018,
  2. More Protection of Lactobacillus acidophilus Than Bifidobacterium bifidum Probiotics on Azoxymethane-Induced Mouse Colon Cancer pp.1867-1314, 2018,